Skip to main content

Magnetic Nanohybrids for Cancer Therapy

Project description

Collaboration for nanoparticles in cancer therapy

Nanotechnology, the study of extremely small particles, has immense application potential in medical research. Iron-oxide nanoparticles will have an important role in cancer therapy, diagnosis and surgery in the near future. The MaNaCa project will create a base for research and for scientific and technological efficiency. The Institute of the National Academy of Sciences (IPR-NAS) in Armenia will network with Greece’s Aristotle University in Thessaloniki, and the German University of Duisburg-Essen. Together, they will be supported by the consultancy company Intelligentsia Consultants Sarl on the subject of magnetic nanohybrids used in cancer therapy for three years.

Call for proposal

H2020-WIDESPREAD-2018-2020

See other projects for this call

Sub call

H2020-WIDESPREAD-2018-03

Coordinator

INSTITUTE FOR PHYSICAL RESEARCH OF NATIONAL ACADEMY OF SCIENCES OF ARMENIA
Net EU contribution
€ 356 662,50
Other funding
€ 0,00

Participants (3)

ARISTOTELIO PANEPISTIMIO THESSALONIKIS
Greece
Net EU contribution
€ 173 587,50
Address
Kedea Building, Tritis Septemvriou, Aristotle University Campus
546 36 Thessaloniki

See on map

Region
Θεσσαλονίκη Κεντρική Μακεδονία Βόρεια Ελλάδα
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
UNIVERSITAET DUISBURG-ESSEN
Germany
Net EU contribution
€ 189 250,00
Address
Universitatsstrasse 2
45141 Essen

See on map

Region
Nordrhein-Westfalen Düsseldorf Essen, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
INTELLIGENTSIA CONSULTANTS SARL
Luxembourg
Net EU contribution
€ 78 612,50
Address
35 Cite Am Wenkel
8086 Bertrange

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Luxembourg Luxembourg Luxembourg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00